Retinal Detachment Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The report covers Global Retinal Detachment Treatment Market Size and it is Segmented by Product (Instruments, and Consumables and Accessories), Treatment Type (Pneumatic Retinopexy, Scleral Buckle Surgery, Vitrectomy, and Others), End User (Hospitals and Clinics, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market values are provided in terms of (in USD million) for the above segments.

Retinal Detachment Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Retinal Detachment Treatment Market Size

Retinal Detachment Treatment Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 3.30 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Retinal Detachment Treatment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Global Retinal Detachment Treatment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Retinal Detachment Treatment Market Analysis

The Global Retinal Detachment Treatment Market is expected to register a CAGR of 3.3% during the forecast period.

COVID-19 impacted the growth of the retinal detachment treatment market. The lockdown measures and restrictions imposed by the government have disrupted the treatment services in eye hospitals and clinics, which has decreased the demand for instruments. For instance, according to a study published in the British Journal of Ophthalmology in November 2021, in France, there was a 41.6% decline in rhegmatogenous retinal detachment (RRD) procedures from the pre-pandemic period to the pandemic period. Thus, the decreased surgical procedures for RD have decreased the demand for instruments, accessories, and other surgical products, which has impacted market growth during the pandemic period. However, with the resumed procedures and increased hospital visits, the demand for eye surgeries has increased. Thus, the market is expected to grow and regain its full potential in the coming few years.

Factors such as an aging population and an increase in the prevalence of diabetic retinopathy and other eye diseases among the population are driving market growth.For instance, according to 2022 statistics published by the CDC, about 20.5 million people living in America aged 40 years and older have a cataract in at least one eye, and this number is projected to reach 30 million by 2028. Thus, the expected increase in the number of people suffering from cataracts raises the demand for effective surgical procedures and treatment options, which in turn is anticipated to fuel market growth over the forecast period.

Also, as the number of people with diabetes rises, the risk of getting diabetic retinopathy will likely rise, which will increase the demand for effective treatments and help the market grow.For example, according to the IDF's 2022 statistics, about 537 million people around the world had diabetes in 2021, and this number is expected to rise to 643 million in 2030 and 784 million in 2045.So, the growth of the market over the next few years will be driven by the expected rise in the number of people with diabetes.

Also, more people are becoming aware of eye diseases like cataracts, glaucoma, dry eye disease, and others. This raises the demand for eye treatments, which is expected to help the market grow over the next few years.For example, an article in Healthcare from June 2021 says that between November 15, 2020, and January 15, 2021, a study was done to find out how much the general population of the Hail Region in Saudi Arabia knows about common eye problems and what might cause them.31% of the people who took part in the study knew about cataracts, 43% knew about glaucoma, 66% knew about dry eyes, and 44% knew about diabetic retinopathy.The same source also said that 46% of the participants knew about eye conditions, with male participants knowing more than female participants.

So, the studied market is likely to grow over the next few years because of things like the growing number of people with diabetes and eye diseases, as well as the fact that the population is getting older. But the high cost of treatment is likely to slow the growth of the market for retinal detachment treatments over the next few years.

Retinal Detachment Treatment Industry Overview

The retinal detachment treatment market is moderately competitive and consists of several major players. Some of the companies that are currently dominating the market are FCI Ophthalmics, Inami & Co., Ltd., Carl Zeiss Meditec AG, IRIDEX Corporation, and Bausch & Lomb Incorporated, among others.

Retinal Detachment Treatment Market Leaders

  1. Inami & CO.,Ltd

  2. FCI Ophthalmics

  3. IRIDEX Corporation

  4. Carl Zeiss Meditec AG

  5. Bausch & Lomb Incorporated

  6. *Disclaimer: Major Players sorted in no particular order
Retinal Detachment Treatment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Retinal Detachment Treatment Market News

  • December 2022: ASG Eye Hospitals launched a new specialty eye hospital, in Vashi, Navi Mumbai, for the treatment of simple to the most complex eye disorders and diseases. The hospital performs surgery for retinal detachment, including scleral buckling surgery, vitrectomy procedures, and pneumatic retinopexy procedures.
  • April 2022: Carl Zeiss Meditec acquired two manufacturers of surgical instruments - Kogent Surgical, LLC and Katalyst Surgical, LLC to further strengthen its positioning in the industry.

Retinal Detachment Treatment Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Geriatric Population
    • 4.2.2 Increasing Diabetes Retinopathy and Other Eye Diseases
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Treatment
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 Instruments
    • 5.1.2 Consumables and Accessories
  • 5.2 By Treatment Type
    • 5.2.1 Pneumatic Retinopexy
    • 5.2.2 Scleral Buckle Surgery
    • 5.2.3 Vitrectomy
    • 5.2.4 Other Treatment Types
  • 5.3 By End-User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Specialty Clinics
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 FCI Ophthalmics
    • 6.1.2 Inami & CO.,Ltd
    • 6.1.3 Accurate Surgical & Scientific Instruments Corporation
    • 6.1.4 BVI Medical
    • 6.1.5 Carl Zeiss Meditec AG
    • 6.1.6 Bausch & Lomb Incorporated
    • 6.1.7 Nidek Co., Ltd.
    • 6.1.8 Peak Surgicals
    • 6.1.9 Surtex Instruments Limited
    • 6.1.10 IRIDEX Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Retinal Detachment Treatment Industry Segmentation

As per the scope of the report, retinal detachment is caused when the tissue at the back of the eye pulls away from a layer of blood vessels that provide necessary oxygen and nourishment. The Retinal Detachment Treatment market is segmented by product (instruments, consumables, and accessories), treatment type (Pneumatic Retinopexy, Scleral Buckle Surgery, Vitrectomy, and Others), end-user (hospitals and clinics, specialty clinics, and others), and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the market size and forecasts in value (USD million) for the above segments.

By Product Instruments
Consumables and Accessories
By Treatment Type Pneumatic Retinopexy
Scleral Buckle Surgery
Vitrectomy
Other Treatment Types
By End-User Hospitals and Clinics
Specialty Clinics
Other End-Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Retinal Detachment Treatment Market Research FAQs

What is the current Global Retinal Detachment Treatment Market size?

The Global Retinal Detachment Treatment Market is projected to register a CAGR of 3.3% during the forecast period (2025-2030)

Who are the key players in Global Retinal Detachment Treatment Market?

Inami & CO.,Ltd, FCI Ophthalmics, IRIDEX Corporation, Carl Zeiss Meditec AG and Bausch & Lomb Incorporated are the major companies operating in the Global Retinal Detachment Treatment Market.

Which is the fastest growing region in Global Retinal Detachment Treatment Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Global Retinal Detachment Treatment Market?

In 2025, the North America accounts for the largest market share in Global Retinal Detachment Treatment Market.

What years does this Global Retinal Detachment Treatment Market cover?

The report covers the Global Retinal Detachment Treatment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Global Retinal Detachment Treatment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Retinal Detachment Industry Report

Statistics for the 2025 Global Retinal Detachment Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Retinal Detachment Treatment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.